← Back to Search

Yoga (immediate start) group for Cystic Fibrosis

N/A
Waitlist Available
Led By Jennifer Ruddy, MD
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

Cystic fibrosis (CF) is a lung disease that affects 30,000 children and adults in the US. Incorporation of regular exercise into the lives of patients with CF is of interest because it may improve lung function and quality of life. Yoga is an activity that may benefit patients with CF in many ways including strengthening muscles of breathing, improving lung function, and reducing stress which could improve quality of life and adherence to therapies. Yoga has been shown to be beneficial in patients with other lung diseases such as asthma, but has not yet been studied in CF. The investigators hypothesize that yoga will be an activity that is safe and tolerable for CF patients 12 to 25 years of age. The primary aim is to investigate the safety and tolerability of an 8 week yoga program for patients with CF. The secondary aim is to determine the effect of yoga on many aspects of CF disease including respiratory symptoms, adherence to regular CF therapies, quality of life, lung function, exercise tolerance, and nutritional status. The long-term goal is to use the data obtained in this study to design a future study of the efficacy of yoga in a larger population of CF patients at multiple CF centers. This research has the potential to influence the prevention and treatment of CF by providing data which could be used to help understand the most appropriate and beneficial type of physical activity for CF patients.

Eligible Conditions
  • Cystic Fibrosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants with Adverse Events as a Measure of Safety
Pain Scores on the Visual Analog Scale as a measure of tolerability
Secondary outcome measures
BMI
Ease of breathing
Pulmonary function
+3 more

Trial Design

2Treatment groups
Active Control
Group I: Yoga (immediate start) groupActive Control1 Intervention
This arm will start yoga sessions immediately after screening and will continue sessions for 8 weeks. This group will then continue with home yoga for an additional 8 weeks.
Group II: Yoga (waitlist) groupActive Control1 Intervention
This arm will continue regular CF therapies for 8 weeks and will start yoga sessions at week 9.

Find a Location

Who is running the clinical trial?

Firland FoundationUNKNOWN
Seattle Children's HospitalLead Sponsor
301 Previous Clinical Trials
5,216,957 Total Patients Enrolled
7 Trials studying Cystic Fibrosis
41,080 Patients Enrolled for Cystic Fibrosis
Jennifer Ruddy, MDPrincipal InvestigatorSeattle Children's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025